1. 1) The Government of Japan. “National Action Plan on Antimicrobial Resistance (AMR).”: 〈https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000138942.pdf〉, cited 5 September, 2019.
2. 2) Ministry of Health, Labour and Welfare. “Outline of FY 2018 Revision of Medical Fee.”: 〈https://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000196287.pdf〉, cited 5 September, 2019.
3. 3) The Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, The Japanese Society for Infection Prevention and Control, The Japanese Society for Clinical Microbiology, The Pharmaceutical Society of Japan, The Japanese Society of Pharmaceutical Health Care and Sciences, The Japanese Society of Therapeutic Drug Monitoring, The Japanese Society for Medical Mycology Joint Committee, Jpn. J. Chemother., 65, 650-687 (2017).
4. 4) Maeda M., Takuma T., Seki H., Ugajin K., Naito Y., Yoshikawa M., Yamanaka A., Oto Y., Minemura A., Shoji H., Ishino K., Niki Y., J. Infect. Chemother., 22, 90-95 (2016).
5. 5) Barlam T. F., Cosgrove S. E., Abbo L. M., et al., Clin. Infect. Dis., 62, e51-e77 (2016).